KRUSE BO (EVP, CFO, Secy & Treas.) sold 1.6% of their position (4K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $133.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/7/2021ACC: 0001104659-21-077698
DirectorOfficer· EVP, CFO, Secy & Treas.
Since Sep 2018
-4K
Net shares
Net seller
$133.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4K
Price / share
$33.48
Trade value
$133.92K
% of position
1.6%
6/4/2021
253.08K→249.08K
Total
Net shares
−4K
Net value
-$133.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/4/2021 | S · Sale | −4K | $33.48 | $133.92K | 1.6% | 253.08K | 249.08K |
| Total | −4K | -$133.92K | ||||||
Derivative Transactions0
No derivative transactions reported